Earnings calls

Global Health concall ledger

Every earnings call for MEDANTA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

MEDANTA · 6 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 20 May 2026Call held 20 May 2026

MEDANTA Q4 FY26 Earnings Call Transcript & Analysis

EBITDA₹1,134.3 cr+19% YoYEBITDA Margin25.7%PAT₹554.1 cr+15% YoYTotal Income₹4,508.9 cr+20% YoY

EBITDA (ex-Noida, FY26) ₹1,134 cr (+19% YoY); EBITDA Margin (ex-Noida, FY26) 25.7%; PAT (FY26) ₹554 cr (+15% YoY). Total income for FY26 grew 20% YoY to INR 4,508.9 crores.

Read full transcript & analysis

Q3 FY26Published 05 Feb 2026Call held 05 Feb 2026

MEDANTA Q3 FY26 Earnings Call Transcript & Analysis

EBITDA2,494 millionsEBITDA Margin25.4%Adjusted PAT1,224 millionsTotal Income11,428 millions+19% YoY

EBITDA (incl. Noida) 2494 millions; EBITDA Margin (excl. Noida) 25.4%; Adjusted PAT 1224 millions. Total income reached ₹11,428 million, representing a robust 19% YoY growth.

Read full transcript & analysis

Q2 FY26Published 10 Nov 2025Call held 10 Nov 2025

MEDANTA Q2 FY26 Earnings Call Transcript & Analysis

EBITDA2,607 million+6% YoYEBITDA Margin23.3%PAT1,584 million+21% YoYTotal Income11,189 million+15% YoY

EBITDA (including Noida) 2607 million (+6% YoY); EBITDA Margin (including Noida) 23.3%; PAT 1584 million (+21% YoY). Consolidated Total Income reached ₹11,189 million, representing a strong 15% YoY growth.

Read full transcript & analysis

Q1 FY26Published 08 Aug 2025Call held 08 Aug 2025

MEDANTA Q1 FY26 Earnings Call Transcript & Analysis

EBITDA₹255.3 cr+23% YoYEBITDA Margin24.3%PAT₹159 cr+50% YoYPAT Margin15.1%Total Income₹1,051.3 cr+19% YoY

EBITDA ₹255 cr (+23% YoY); EBITDA Margin 24.3%; PAT ₹159 cr (+50% YoY). Total income of ₹1,051.3 crores, up 19% YoY.

Read full transcript & analysis

Q4 FY25Published 16 May 2025Call held 16 May 2025

MEDANTA Q4 FY25 Earnings Call Transcript & Analysis

EBITDA Margin25.4%Adjusted PAT5,186 million+9% YoYTotal Income37,714 million+13% YoY

EBITDA Margin 25.4%; Adjusted PAT 5186 million (+9% YoY); Total Income 37714 million (+13% YoY). FY25 Consolidated Income reached ₹37,714 million, a 13% YoY growth.

Read full transcript & analysis

Q3 FY25Published 05 Feb 2025Call held 05 Feb 2025

MEDANTA Q3 FY25 Earnings Call Transcript & Analysis

EBITDA₹253.8 cr+8% YoYEBITDA Margin27.5%PAT₹142.9 cr+16% YoYTotal Income₹959.5 cr+12% YoY

EBITDA ₹254 cr (+8% YoY); EBITDA Margin 27.5%; PAT ₹143 cr (+16% YoY). Total Income reached ₹959.5 crores, representing a 12% YoY growth.

Read full transcript & analysis